Gastrointestinal Cancer

3:15
Pembrolizumab demonstrates promise in patients with pretreated metastatic gastric cancer
Zev Wainberg
1:29
Using dogs in detecting early stage oesophogeal and stomach cancers
Ian Banks
2:30
EBV and MSI – subsets of gastric cancer that respond better to therapy
Ronan Joseph Kelly
1:56
Can nivolimumab aid in preventing gastrointestinal cancer progression?
Ronan Joseph Kelly
1:55
Combination immunotherapy in gastrointestinal cancers: highlights from ASCO 2017
Hendrik-Tobias Arkenau
1:44
Reducing the neurotoxic side effects of adjuvant chemotherapy for colon cancer
Hendrik-Tobias Arkenau
1:40
The BILCAP study: a better overal survivial of biliary tract cancers with adjuvant capecitabine
Hendrik-Tobias Arkenau
1:53
The origins of EuropaColon
Jola Gore-Booth
1:19
The European colorectal cancer (CRC) awareness month in March
Jola Gore-Booth
4:01
The importance of screening programs for colorectal cancer (CRC) and the EuropaColon task force
Jola Gore-Booth
1:08
The importance of providing information to patients with colorectal cancer
Geoffrey Henning
1:44
EuropaColon survey of the unmet needs of metastatic colorectal cancer patients
Geoffrey Henning
2:01
Reasons why patients accept or decline gastrointestinal cancer clinical trials
Cyper Allen
3:46
Overview of RAPIDO trial in rectal cancer and FOxTROT trial in colon cancer
David Sebag-Montefiore
1:46
Immunotherapy for lung cancer and trial of ramucirumab plus pembrolizumab
Roy Herbst
0:35
Occurence of APOBEC mutagenesis in human cancers
Reuben Harris
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJOncology is intended for healthcare professionals